CURIS INC 8-K

What Happened

• Curis, Inc. (CRIS) filed an 8-K dated May 1, 2026 reporting that on April 27, 2026 Nasdaq's Listing Qualifications Staff issued a Delist Determination Letter because the company's common stock closed below the $1.00 minimum bid price for 30 consecutive business days (Nasdaq Listing Rule 5550(a)(2)).
• Curis is currently subject to a one-year Discretionary Panel Monitor that began on February 3, 2026 under Listing Rule 5815(d)(4)(A). The company intends to timely request a hearing before a Nasdaq Hearings Panel by the May 4, 2026 deadline, which will stay further delisting actions pending the hearing. The delisting and suspension would take effect at the open of trading on May 6, 2026 if no timely appeal is filed.

Key Details

• Delist Determination Letter dated: April 27, 2026.
• Nasdaq rule cited for bid-price deficiency: Listing Rule 5550(a)(2) (minimum $1.00 bid).
• Monitoring status began: February 3, 2026 under Listing Rule 5815(d)(4)(A) (one-year Discretionary Panel Monitor).
• Appeal deadline to request a hearing: May 4, 2026; scheduled suspension if no appeal: opening of trading May 6, 2026.
• 8-K signed by: Diantha Duvall, Chief Financial Officer; filing date: May 1, 2026.

Why It Matters

• If the delisting is upheld and the company’s shares are suspended from the Nasdaq Capital Market, trading and liquidity for CRIS shares could be materially affected and shareholder access to capital markets could be constrained.
• Curis has the right to request a hearing, and filing a timely appeal will temporarily halt Nasdaq’s delisting action, but the company explicitly warns there is no assurance the appeal will succeed or that it will remain listed.
• Investors should monitor the outcome of the Nasdaq hearing request and any additional company disclosures, as the decision will directly affect where and how Curis shares trade and could influence investor liquidity and market perception.